Background:Bile acids(BAs)facilitate the progression of gastric intestinal metaplasia(GIM).Long non-coding RNAs(lncRNAs)dysregulation was observed along with the initiation of gastric cancer.However,how lncRNAs functi...Background:Bile acids(BAs)facilitate the progression of gastric intestinal metaplasia(GIM).Long non-coding RNAs(lncRNAs)dysregulation was observed along with the initiation of gastric cancer.However,how lncRNAs function in GIM remains unclear.This study aimed to explore the role and mechanism of lncRNA PVT1 in GIM,and provide a potential therapeutic target for GIM treatment.Methods:We employed RNA sequencing(RNA-seq)to screen dysregulated lncRNAs in gastric epithelial cells after BA treatment.Bioinformatics analysis was conducted to reveal the regulatory mechanism.PVT1 expression was detected in 21 paired biopsies obtained under endoscopy.Overexpressed and knockdown cell models were established to explore gene functions in GIM.Molecular interactions were validated by dual-luciferase reporter assay,RNA immunoprecipitation(RIP),and chromatin immunoprecipitation(Ch-IP).The levels of relative molecular expression were detected in GIM tissues.Results:We confirmed that lncRNA PVT1 was upregulated in BA-induced GIM model.PVT1 promoted the expression of intestinal markers such as CDX2,KLF4,and HNF4α.Bioinformatics analysis revealed that miR-34b-5p was a putative target of PVT1.miR-34b-5p mimics increased CDX2,KLF4,and HNF4αlevels.Restoration of miR-34b-5p decreased the pro-metaplastic effect of PVT1.The interactions between PVT1,miR-34b-5p,and the downstream target HNF4α were validated.Moreover,HNF4αcould transcriptionally activated PVT1,sustaining the GIM phenotype.Finally,the activation of the PVT1/miR-34b-5p/HNF4α loop was detected in GIM tissues.Conclusions:BAs facilitate GIM partially via a PVT1/miR-34b-5p/HNF4α positive feedback loop.PVT1 may become a novel target for blocking the continuous development of GIM and preventing the initiation of gastric cancer in patients with bile reflux.展开更多
基金supported by grants from the National Natural Science Foundation of China(Nos.82170560,82200567,and 82330110)the Booster Plans of Xijing Hospital(No.XJZT21L07)Healthcare lnnovation Capability Enhancement Plan in Shaanxi Province(No.2024TD-06).
文摘Background:Bile acids(BAs)facilitate the progression of gastric intestinal metaplasia(GIM).Long non-coding RNAs(lncRNAs)dysregulation was observed along with the initiation of gastric cancer.However,how lncRNAs function in GIM remains unclear.This study aimed to explore the role and mechanism of lncRNA PVT1 in GIM,and provide a potential therapeutic target for GIM treatment.Methods:We employed RNA sequencing(RNA-seq)to screen dysregulated lncRNAs in gastric epithelial cells after BA treatment.Bioinformatics analysis was conducted to reveal the regulatory mechanism.PVT1 expression was detected in 21 paired biopsies obtained under endoscopy.Overexpressed and knockdown cell models were established to explore gene functions in GIM.Molecular interactions were validated by dual-luciferase reporter assay,RNA immunoprecipitation(RIP),and chromatin immunoprecipitation(Ch-IP).The levels of relative molecular expression were detected in GIM tissues.Results:We confirmed that lncRNA PVT1 was upregulated in BA-induced GIM model.PVT1 promoted the expression of intestinal markers such as CDX2,KLF4,and HNF4α.Bioinformatics analysis revealed that miR-34b-5p was a putative target of PVT1.miR-34b-5p mimics increased CDX2,KLF4,and HNF4αlevels.Restoration of miR-34b-5p decreased the pro-metaplastic effect of PVT1.The interactions between PVT1,miR-34b-5p,and the downstream target HNF4α were validated.Moreover,HNF4αcould transcriptionally activated PVT1,sustaining the GIM phenotype.Finally,the activation of the PVT1/miR-34b-5p/HNF4α loop was detected in GIM tissues.Conclusions:BAs facilitate GIM partially via a PVT1/miR-34b-5p/HNF4α positive feedback loop.PVT1 may become a novel target for blocking the continuous development of GIM and preventing the initiation of gastric cancer in patients with bile reflux.